PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
21-Aug-2020 Glasgow dentists sign up for new Oxford University coronavirus killing technology Commonwealth Dental Practice
21-Aug-2020 GC Aesthetics announces the release of minimal-touch insertion device, HydroCone GC Aesthetics Ltd
21-Aug-2020 Oxitec Announces Landmark Approval of Florida Keys Pilot Project to Combat Mosquito that Transmits Dengue, Zika Oxitec
21-Aug-2020 Orgenesis Selects Therapeutics, Inc. as CRO to Support Development and Planned Phase 2 Clinical Study of Ranpirnase for the Treatment of External Genital Warts Orgenesis Inc.
21-Aug-2020 Helsinn Group announces AKYNZEO® injection – a new liquid IV solution – now available in the US Helsinn Group
21-Aug-2020 Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19 Pfizer and BioNTech
21-Aug-2020 Imfinzi approved in Japan for the treatment of extensive-stage small cell lung cancer AstraZeneca PLC
20-Aug-2020 Tiziana is Pleased to Retain Dr. Napoleone Ferrara to Serve on Its Scientific Advisory Board for an Additional Three-Year Term Tiziana Life Sciences
20-Aug-2020 Ingenza meets a key milestone in the deployment of novel cost-effective COVID-19 vaccine technology Ingenza
20-Aug-2020 Verona Pharma Initiates Multiple Dose Part of Phase 2 Clinical Trial with pMDI Formulation of Ensifentrine in COPD Verona Pharma plc
20-Aug-2020 Emergex and Bio-Manguinhos/Fiocruz Elucidate T Cell Epitopes Produced by Commercial Yellow Fever Vaccine Emergex Vaccines Holding Limited
20-Aug-2020 Intravacc's candidate RSV vaccine demonstrates safety in phase I trial Intravacc
20-Aug-2020 Imfinzi granted FDA Priority Review for less-frequent, fixed-dose use AstraZeneca
20-Aug-2020 Latest Clinical Research Evaluating VASCEPA® (Icosapent Ethyl) in Patients with Residual Cardiovascular Risk to be Presented at ESC Congress 2020, the Annual Meeting of the European Society of Cardiology Amarin Corporation plc
20-Aug-2020 Kiadis collaborates with premier Dutch institutions to apply K-NK-cell technology for the development of a novel COVID-19 therapy Kiadis Pharma N.V.
14-Aug-2020 Akshaya Patra foundation and Cadila Pharma help 3000 students at their homes through mid-day meals Cadila Pharmaceuticals Ltd
14-Aug-2020 UNION therapeutics A/S enters option agreement to acquire worldwide exclusive license for COVID-19 technologies developed by TFF Pharmaceuticals, Inc. UNION therapeutics A/S
14-Aug-2020 Sosei Heptares Operational Highlights and Consolidated Results for the First Half 2020 Sosei Heptares
14-Aug-2020 Bone Therapeutics receives EUR 1.0 million to advance ongoing JTA-004 phase III knee osteoarthritis study Bone Therapeutics
14-Aug-2020 Daridorexant Phase 3 results in insomnia to be presented at SLEEP 2020 Idorsia Ltd